Get started
Live feed
PRReleasevia Quantisnow
Mangoceuticals Inc. logo

Mangoceuticals’ Merger Partner, Nuclea Energy Inc., Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Historical context for MGRX

Across the 11 sessions after earlier MGRX headlines, the stock closed higher 4 times and lower 7 times, with a median move of 23.9% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

MGRX close-to-close change in the session after earlier headlines
SessionEarlier headlineMGRXSPY
Aug 6, 2026Nuclea Energy USA Inc. Announces MOU with Utah Office of Energy Developmentand 1 other headline that session+23.9%-0.2%
Aug 5, 2026Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination-7.1%-0.2%
Jul 30, 2026Nuclea Energy Enters Definitive Business Combination Agreement with Mangoceuticals, Establishing a Path to a Nasdaq Public Listing to Advance the Morpheus Microreactorand 1 other headline that session-46.9%+1.7%
Mar 18, 2026Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc.-7.0%-1.4%
Mar 9, 2026Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds-7.0%+0.9%
Feb 24, 2026Mangoceuticals' Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study-3.9%+0.7%

Keep researching MGRX

Quantisnow market dataNASDAQ
Mangoceuticals Inc. logo
MGRX
Mangoceuticals Inc.
Market cap
30-day
Sector
Health Care
Industry
Misc Health and Biotechnology Services
Listed since
2023
Get push alerts for MGRX

Follow MGRX and get a push notification the moment its next story breaks.

Full MGRX profile on Quantisnow

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MGRX (Mangoceuticals Inc.) and more on Quantisnow.